| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 治疗和/或预防剖腹产分娩的婴儿感染的方法 | CN200680047332.9 | 2006-10-06 | CN101330837A | 2008-12-24 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含糖醛酸低聚糖的且用于制造对剖腹产分娩的婴儿进行肠道给予的一种组合物的应用。 | ||||||
| 2 | 促进非自然分娩后的肠屏障完整成熟的方法 | CN201310722592.3 | 2006-10-06 | CN103816173B | 2017-12-12 | 琼希姆·施密特; 巩特尔·勃姆; 克里斯托弗·比尔曼 |
| 本申请涉及促进非自然分娩后的肠屏障完整成熟的方法。本发明涉及喂养及促进剖腹产婴儿健康的方法，包括给予剖腹产婴儿长链多不饱和脂肪酸和/或核苷酸。 | ||||||
| 3 | 刺激肠内菌群的方法 | CN201310148476.5 | 2006-10-20 | CN103230005B | 2016-03-16 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a）至少两种不同的微生物；或b）至少一种微生物和至少一种不消化的寡糖；或c）至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 4 | 预防剖腹产分娩的婴儿疾病的方法 | CN201210414761.2 | 2006-10-06 | CN102919663B | 2015-08-19 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 5 | 预防剖腹产分娩的婴儿疾病的方法 | CN200680047651.X | 2006-10-06 | CN101330838B | 2013-01-23 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 6 | 促进非自然分娩后的肠屏障完整成熟的方法 | CN201310722592.3 | 2006-10-06 | CN103816173A | 2014-05-28 | 琼希姆·施密特; 巩特尔·勃姆; 克里斯托弗·比尔曼 |
| 本申请涉及促进非自然分娩后的肠屏障完整成熟的方法。本发明涉及喂养及促进剖腹产婴儿健康的方法，包括给予剖腹产婴儿长链多不饱和脂肪酸和/或核苷酸。 | ||||||
| 7 | 刺激肠内菌群的方法 | CN201310148476.5 | 2006-10-20 | CN103230005A | 2013-08-07 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a）至少两种不同的微生物；或b）至少一种微生物和至少一种不消化的寡糖；或c）至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 8 | 预防剖腹产分娩的婴儿疾病的方法 | CN201210414761.2 | 2006-10-06 | CN102919663A | 2013-02-13 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 9 | 预防剖腹产分娩的婴儿疾病的方法 | CN200680047651.X | 2006-10-06 | CN101330838A | 2008-12-24 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物的应用，这种组合物适用于肠道给予剖腹产婴儿。 | ||||||
| 10 | 刺激肠内菌群的方法 | CN200680035474.3 | 2006-10-20 | CN101272701A | 2008-09-24 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a)至少两种不同的微生物；或b)至少一种微生物和至少一种不消化的寡糖；或c)至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 11 | METHOD FOR CULTURING LACTIC ACID BACTERIUM AND METHOD FOR PRODUCING FERMENTED MILK | US13260249 | 2010-03-26 | US20120015073A1 | 2012-01-19 | Masayuki Kamijo |
| First, prepared is a whey degradation medium to which a protease, yeast extract, and the like are added. Further, polyoxyethylene sorbitan monooleate or propylene glycol monooleate is added to the whey degradation medium. The whey degradation medium is inoculated with bacteriocin-producing lactic acid bacterium and the lactic acid bacterium is cultured while the whey degradation medium is maintained at pH of 4 to 5. After the completion of the culture, the whey degradation medium (culture solution) is centrifuged to thereby separate therefrom a concentrated cell suspension containing the lactic acid bacterium in a concentrated form. The concentrated cell suspension has very low antibacterial activity (several tens AU or less). Then, by adding the concentrated cell suspension to a yogurt mix and fermenting the same, it is possible to produce yogurt containing the bacteriocin-producing lactic acid bacterium without any delay in the fermentation. | ||||||
| 12 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | US12091047 | 2006-10-06 | US20090263537A1 | 2009-10-22 | Joachim Schmitt; Gunther Boehm |
| The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides | ||||||
| 13 | 乳酸菌の培養法および発酵乳の製造法 | JP2011507162 | 2010-03-26 | JP5660629B2 | 2015-01-28 | 政幸 上條 |
| 14 | Prevention of a disease in infants which are birth by caesarean section | JP2008536530 | 2006-10-06 | JP2009512686A | 2009-03-26 | クノール、ヤン; シュミット、ヨアヒム; スタール、ベルント |
| 本発明は、帝王切開により出産された乳幼児に経腸的に投与するための組成物の製造のための、非消化性オリゴ糖を含む組成物の使用を提供する。
【選択図】 なし |
||||||
| 15 | 乳酸菌の培養法および発酵乳の製造法 | JP2011507162 | 2010-03-26 | JPWO2010113816A1 | 2012-10-11 | 政幸 上條 |
| 最初に、プロテアーゼ、酵母エキスなどが添加されたホエイ分解培地を調製する。さらに、ホエイ分解培地には、モノオレイン酸ポリオキシエチレンソルビタン、またはモノオレイン酸プロピレングリコールが添加される。ホエイ分解培地にバクテリオシンを生産する乳酸菌を接種し、ホエイ分解培地のpHを4〜5に維持しながら乳酸菌を培養する。培養後のホエイ分解培地(培養液)を遠心分離して、乳酸菌が濃縮された濃縮菌液を分離する。濃縮菌液は、非常に低い抗菌活性(数10AU以下)を示す。上記の濃縮菌液をヨーグルトミックスに添加して発酵させることにより、バクテリオシンを生産する乳酸菌を含むヨーグルトを、発酵遅延を発生させることなく製造することができる。 | ||||||
| 16 | Method for stimulating the intestinal flora | US14973166 | 2015-12-17 | US09596876B2 | 2017-03-21 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 17 | Preventing diseases in infants delivered via caesarean section | US14813845 | 2015-07-30 | US09585416B2 | 2017-03-07 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 18 | Method for culturing lactic acid bacterium and method for producing fermented milk | US13260249 | 2010-03-26 | US09426999B2 | 2016-08-30 | Masayuki Kamijo |
| First, prepared is a whey degradation medium to which a protease, yeast extract, and the like are added. Further, polyoxyethylene sorbitan monooleate or propylene glycol monooleate is added to the whey degradation medium. The whey degradation medium is inoculated with bacteriocin-producing lactic acid bacterium and the lactic acid bacterium is cultured while the whey degradation medium is maintained at pH of 4 to 5. After the completion of the culture, the whey degradation medium (culture solution) is centrifuged to thereby separate therefrom a concentrated cell suspension containing the lactic acid bacterium in a concentrated form. The concentrated cell suspension has very low antibacterial activity (several tens AU or less). Then, by adding the concentrated cell suspension to a yogurt mix and fermenting the same, it is possible to produce yogurt containing the bacteriocin-producing lactic acid bacterium without any delay in the fermentation. | ||||||
| 19 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US14813845 | 2015-07-30 | US20150335053A1 | 2015-11-26 | Joachim SCHMITT; Bernd STAHL; Jan KNOL |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 20 | Preventing diseases in infants delivered via caesarean section | US14135171 | 2013-12-19 | US09107438B2 | 2015-08-18 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
QQ群二维码
意见反馈
意见反馈